MDM2 and cancer: For instance, DUBs have been proposed to play a critical role in regulating NF-κB pathway [36], TGFβ signaling [37] as well as p53 and MDM2 [38] levels and activity suggesting that DUB dysregulation is a frequent event in cancer.